Generics in cattle: Are they all created the same?
American Association of Bovine Practitioners Conference Proceedings · 28.04.2026 · 58 (2) · 35-38
DOI: 10.21423/aabppro20259330 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Association of Bovine Practitioners Conference Proceedings, online erschienen am 28.04.2026. Verfasst von Nora Schrag.
Abstract (Originalsprache)
Understanding the basic types of drug product approval applications can be helpful when selecting products to recommend for use within a particular livestock system. Products that do not have an NADA or ANADA number have not been through any type of FDA approval process. Products with an ANADA, commonly referred to as “generics”, have an abbreviated approval process through the FDA. Many products necessary for daily practice are listed in the FDA’s Green Book. This document gives several examples of specific approval types, and how that relates to the effectiveness evidence for the product in the bottle. Both a solid understanding of the effectiveness evidence generated by the approval process, as well as the context within which the product will be used, is necessary to make recommendations for use of these products within livestock systems.
Zitieren
APA
Schrag, N. (2026). Generics in cattle: Are they all created the same?. American Association of Bovine Practitioners Conference Proceedings, 58(2), 35-38. https://doi.org/10.21423/aabppro20259330
Vancouver
Schrag N. Generics in cattle: Are they all created the same?. American Association of Bovine Practitioners Conference Proceedings. 2026;58(2):35-38. doi:10.21423/aabppro20259330
BibTeX
@article{Schrag2026,
author = {Schrag, Nora},
title = {Generics in cattle: Are they all created the same?},
journal = {American Association of Bovine Practitioners Conference Proceedings},
year = {2026},
volume = {58},
number = {2},
pages = {35--38},
doi = {10.21423/aabppro20259330}
}
EUVIMED